Li Zhen
Reporting owner on Forms 3, 4 and 5, CIK 1729510.
Li Zhen reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-09-28.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ADARx Pharmaceuticals, Inc. CIK 1802369 | director, officer (President and CEO), 10% owner | 1 | 2026-09-28 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ADARx Pharmaceuticals, Inc. Employee Stock Option (right to buy), derivative | 2026-09-24 | A granted | +1,024,152 | $0 | 1,024,152 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001729510-26-000006 | ADARx Pharmaceuticals, Inc. | 2026-09-28 |